Showing results (201-210 of 236) with videos related to
Sort By:
Pageof 24
BMC Cancer|August 22, 2018
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse modelTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.Anticancer Research|September 15, 2019
Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of OsteosarcomaTakashi Higuchi, Hiromichi Oshiro, Kentaro Miyake, et al.Journal of Dental Sciences|January 1, 2021
A comparison of colorimetric and visual methods for the assessment of masticatory performance with color-changeable chewing gum in older personsYoshihiro Kugimiya, Yutaka Watanabe, Maki Shirobe, et al.Cancer Diagnosis & Prognosis|September 3, 2025
Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant MethioninaseYohei Asano, Toshihiko Sato, Qinghong Han, et al.Anticancer Research|May 6, 2020
Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated LiposarcomaKentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.Gerodontology|July 2, 2025
Descriptive Epidemiology of Oral Function in Middle-Aged and Older Japanese IndividualsMaki Shirobe, Masanori Iwasaki, Kentaro Igarashi, et al.Anticancer Research|December 25, 2016
Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxelTakashi Murakami, Takuya Murata, Kei Kawaguchi, et al.Cell Cycle (Georgetown, Tex.)|December 1, 2017
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and preventionKei Kawaguchi, Qinghong Han, Shukuan Li, et al.Cancer Genomics & Proteomics|April 30, 2020
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse ModelKentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, et al.Cell Cycle (Georgetown, Tex.)|May 12, 2017
Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse modelKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.Pageof 24